• Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium
  • Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium
  • Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium
  • Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium
  • Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium
  • Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium

Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium

Function: Vitamins and Minerals Deficiency Drug
Grade Standard: Medicine Grade
Type: Chemical Reagent
State: Powder
Volatile: Not Volatile
CAS: 134523-03-8
Samples:
US$ 320/kg 1 kg(Min.Order)
| Request Sample
Customization:
Gold Member Since 2022

Suppliers with verified business licenses

Anhui, China
Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (14)

Basic Info.

Model NO.
py0434
Mf.
C66h68caf2n4o10
Einecs
200-659-6
Standard
USP Bp Ep
Transport Package
10kg/Drum
Specification
99%
Trademark
puya
Origin
China
Production Capacity
10ton/Year

Product Description

CAS 134523-03-8 Atorvastatin Calcium

CAS: 134523-03-8
MF: C66H68CaF2N4O10
MW: 1155.36
EINECS: 200-659-6
Melting point: 176-178°C
Storage temp.: Store at +4°C
Appearance: White Crystalline Powder

Pharmaceutical Raw Material Powder CAS 134523-03-8 Atorvastatin Calcium
Specification
Items Standard Results
APPEARANCE Off white to white powder White powder
IDENTIFICATION A: IR
B: Retention time
Complies
Complies
WATER 0.5% 0.06%
HEAVY METALS ≤0.002% Complies
ISOMERS SFBD1≤0.15% Undetected
  SFBD2≤0.15% Undetected
  SFBE≤0.15% Undetected
RELATED SUBSTANCES SFBA-1≤0.15% 0.04%
  SFBMA≤0.15% Undetected
  CHLORO-SFB≤0.15% 0.05%
  DiSFBMA-SFB≤0.15% 0.02%
  Methyl-SFB≤0.15% Undetected
  Pentafluoro-phenol≤0.15% Undetected
  Amino-SFB≤0.15% Undetected
  Any unknown impurity≤0.1% 0.04%
  Total impurity≤1.0% 0.21%
ASSAY ≥99.0% 99.8%
RESULT:  It complies to prescribed enterprise standard

Function
Lipitor was launched in Canada, the Netherlands, the UK and the US as an orally-active hypocholesterolemic agent.
It was the first pharmaceutical product ever to attain over one billion dollars in sales in its first year. It can be
synthesized by a number of routes but the most efficient involves the Paal-Knorr reaction of an acetonide protected
dihydroxy amino ester and a diaryl phenylacetamide diketone. Lipitor is a liver selective, reversible competitive
inhibitor of HMG-CoA reductase, the rate limiting step in cholesterol biosynthesis. Lipitor monotherapy resulted
in a reduction of LDL cholesterol by up to 60%. Lipitor is about 2-4 times more potent, on a dosage basis, than
Simvastatin.


Application
A selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated
for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia..

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2022

Suppliers with verified business licenses

Trading Company
Number of Employees
3
Year of Establishment
2023-04-18